QIAGEN N.V. (QIA) Wins FDA Clearance, Completing U.S. QIAstat-Dx BSI Portfolio
QIAGEN received FDA clearance for its QIAstat-Dx BCID GN Plus AMR Panel, enabling U.S. labs to run both gram-negative and gram-positive/fungal bloodstream infection panels on QIAstat-Dx with ~1-hour results.Material DetailsContext by AI AnalystThis is a mid-cycle expansion of QIAGEN’s syndromic tes…